Biopharma Co. Sued After Leukemia Treatment Trial Fails
By Dean Seal ( October 4, 2018, 8:55 PM EDT) -- A TG Therapeutics Inc. stockholder filed a proposed class action in New York federal court on Thursday accusing the biopharmaceutical company of making optimistic statements about the clinical trial performance of two drugs used to treat leukemia despite knowing that the drug therapy had failed....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.